IDH2 and central nervous system cancer: IDH1 and IDH2 mutations frequently exist in multiple human malignancies, including acute myeloid leukemia (AML), glioma, glioblastoma, chondrosarcoma, and cholangiocarcinoma [159,160,161,162].